Cervical Intraepithelial Neoplasia News and Research

RSS
Advaxis doses first patient in FDA-approved phase II CIN trial

Advaxis doses first patient in FDA-approved phase II CIN trial

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

Advaxis initiates Phase 2 clinical trial of ADXS11-001 for treatment of CIN

Enrollment completes for Inovio Biomedical's dose escalation phase I trial of cervical cancer vaccine

Enrollment completes for Inovio Biomedical's dose escalation phase I trial of cervical cancer vaccine

Health Canada approves GARDASIL for prevention of genital warts in males

Health Canada approves GARDASIL for prevention of genital warts in males

HPV DNA testing vital in identification of cervical cancer

HPV DNA testing vital in identification of cervical cancer

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Overall benefits of HPV vaccination or frequent screening are low for women over 41

Overall benefits of HPV vaccination or frequent screening are low for women over 41

Positive interim results from Helix BioPharma's Topical Interferon Alpha-2b Phase II pharmacokinetic study

Positive interim results from Helix BioPharma's Topical Interferon Alpha-2b Phase II pharmacokinetic study

Advaxi to receive fund from CRUK for clinical trial of ADXS11-001

Advaxi to receive fund from CRUK for clinical trial of ADXS11-001

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

Inovio Biomedical announces additional immunogenicity data from therapeutic cervical cancer vaccine trial

HPV vaccination programs may reduce genital diseases

HPV vaccination programs may reduce genital diseases

USPTO issues new patent for Advaxis' intellectual property portfolio

USPTO issues new patent for Advaxis' intellectual property portfolio

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

HPV testing could be used as standard method of cervical screening for women, say Italian scientists

EPO approves Advaxis patent application for Listeria Antigens

EPO approves Advaxis patent application for Listeria Antigens

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

Advaxis to collaborate with GOG in Phase II clinical trial of ADXS11-001

Advaxis to collaborate with GOG in Phase II clinical trial of ADXS11-001

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

Epitope spreading can get triggered by live, attenuated Listeria vaccine

Epitope spreading can get triggered by live, attenuated Listeria vaccine